It's also hilarious to see them complain endlessly about
It's also hilarious to see them complain endlessly about how the game is completely rigged against all OTC stocks and their investors, while at the same time purporting to be averaging down all the way from +$6.00 down to a dime on such a rigged OTC stock.
Furthermore, it's not as if JBII is their first ride at the rodeo. The posting history of these complainers show them repeating this same pattern of behavior continuously over the past 7-10 years. Each time they start loading up at the top of some shady OTC stock pumped up on some fishy story, and then they complain continuously for the next few years about how the game is rigged on the OTC as they price-average-down their stock to $0.0001 or bankruptcy. EVERY SINGLE TIME.
Whenever anyone asks them why they threw themselves back into the same frying again for the dozenth time with JBII, their answer is something like: "Oh, this one will be different. It will finally be the one that beats the nefarious colluders, entities, PROs, and corrupt government agencies at their own game".
And so it will go on for another decade, I suspect.
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...
Continue Reading
Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....
Continue Reading
Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...
Continue Reading
Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...
Continue Reading
Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...
Continue Reading